Letter: Use and toxicity of nitroprusside.
D000409:Alanine / Q000627:therapeutic use; D000804:Angiotensin II / Q000031:analogs & derivatives / Q000037:antagonists & inhibitors / Q000627:therapeutic use; D000818:Animals; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000633:toxicity*; D003486:Cyanides / Q000506:poisoning; D005292:Ferricyanides / Q000008:administration & dosage / Q000627:therapeutic use* / Q000633:toxicity; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D012377:Rodentia; D012521:Sarcosine / Q000627:therapeutic use
D000959:Antihypertensive Agents; D003486:Cyanides; D005292:Ferricyanides; D000804:Angiotensin II; D000409:Alanine; D012521:Sarcosine